NCT05099055View on ClinicalTrials.gov

Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

January 20, 2023

Study Completion Date

May 5, 2023

Conditions
AnalgesiaAnalgesics, OpioidAnesthesia, ObstetricalAnesthesia, SpinalAnalgesics, Non-NarcoticDexmedetomidineAnalgesia, Obstetrical
Interventions
DRUG

Dexmedetomidine 0.004 MG/ML [Precedex]

Injection of 3 mcg of dexmedetomidine and 12 mg of bupivacaine in the intrathecal space to provide spinal anesthesia.

DRUG

Opioids

Injection of 100 mcg of morphine, 15 mcg of fentanyl and 0.25 ml of normal salin (sterile) with 12 mg of bupivacaine in the intrathecal space to provide spinal anesthesia.

Trial Locations (1)

H3T 1C5

Ste-Justine Hospital, Montreal

All Listed Sponsors
lead

St. Justine's Hospital

OTHER